Dr. Hadi Saleh was appointed CEO of the CeramTec Group on March 8, 2018. He previously spent three years as Chief Operating Officer of CeramTec’s Executive Board, responsible for the Medical Applications Segment.
Prior to joining CeramTec, Dr. Saleh worked in the medical technology sector, as Senior Vice President of Biomet Inc. and President of Biomet International where he was previously responsible for all Biomet product lines worldwide outside of the US and Europe. In addition, he played a leading role in the Zimmer Holdings acquisition of Biomet Inc. Dr. Saleh held a number of positions at Biomet, first at Biomet Germany, then Biomet Europe and finally at the parent company, Biomet Inc. in Warsaw, IN in the United States.
Dr. Saleh started his career as an orthopaedic surgeon at St. Josef’s Hospital in Wiesbaden and at the University Clinic in Heidelberg and was a Senior Consultant at GAIA in Hamburg.
He earned his doctorate at Frankfurt am Main and Mainz.
On September 15, 2018, Eric Oellerer was appointed as Chief Financial Officer (CFO) to the CeramTec Group management board. In his most recent position as CFO and COO of Metabowerke GmbH, where he was since 2011, Eric Oellerer held joint responsibility for the restructuring of the company, including a marked improvement in profitability. Before that, he served as portfolio manager at HgCapital for three years, after being at Daimler/Mercedes-Benz, where he after some years in M&A was responsible for various companies in the role as CFO.
Eric Oellerer has a master’s degree in Business Administration from the Rotterdam School of Management, Erasmus University, Netherlands, and a Magister Juris from the University of Vienna, Austria.
As of February 1, 2023, Dr.-Ing. habil. Katrin Sternberg joined the CeramTec Group as President Medical and Member of the Executive Board. Previously, she was employed at B. Braun Aesculap since 2014, where she was a member of the Management Board and, since 2018, also Member of the Executive Board. Most recently, she was responsible for Research & Development, Quality Management, Regulatory Affairs and Medical Scientific Affairs.
Prior to her involvement in the medical device industry, Dr. Sternberg worked extensively in science, including as Professor of Biomedical Engineering at the University of Rostock from 2009 - 2014. Dr. Sternberg holds a PhD in Chemistry from the University of Rostock and completed her habilitation from the Institute of Biomedical Engineering at the University of Rostock.
Horst W. Garbrecht assumed the position of President of the Industrial Division on 1. January 2022. With an engineering background, he most recently for 12 years led the power tool manufacturer Metabowerke GmbH with the well-known Metabo brand in the capacity of CEO. Since 2019, he was concurrently COO Europe of the Japanese parent company Koki Holdings and thus also responsible for the European business of the sister brand HiKOKI. In previous stages of his career, he was Managing Director and COO at the Swedish machine manufacturer Atlas Copco and later at the Hong Kong-Chinese company Techtronic Industries. His professional career as an engineer began at the power tool manufacturer Festool.
Horst Garbrecht is a qualified supervisory board member of Deutsche Börse and has been a member of the supervisory board of Basler AG (Computer Vision) in Hamburg since 2015. He was President of the European Power Tools Association (EPTA) from 2016 to 2021 and holds a degree in mechanical engineering / energy technology from Esslingen University of Applied Sciences.